|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1 CAD | -4.76% |
|
0.00% | +400.00% |
| Apr. 26 | BioNeutra Global Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 08 | BioNeutra Global Corporation Appoints Stephen Jakeway as Chief Operating Officer | CI |
BioNeutra Global Corporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CAD 13.39 million compared to CAD 15.4 million a year ago. Net loss was CAD 2.92 million compared to CAD 2.83 million a year ago.
Basic loss per share from continuing operations was CAD 0.06 compared to CAD 0.06 a year ago. Diluted loss per share from continuing operations was CAD 0.06 compared to CAD 0.06 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +400.00% | 3.41M | |
| -4.93% | 261B | |
| -2.51% | 94.98B | |
| +3.19% | 46.39B | |
| +8.74% | 39.99B | |
| -0.65% | 39.95B | |
| -0.15% | 38.02B | |
| -16.78% | 30.16B | |
| -6.61% | 28.72B | |
| +11.32% | 24.54B |
BIONEUTRA GLOBAL CORPORATION 
